Coloplast A/S/€COLOB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Coloplast A/S
Coloplast A/S is a Danish multinational company that specializes in the development and manufacture of medical devices and services. The company's core business operates within the healthcare sector, offering products and services that focus on ostomy care, urology, continence care, and wound and skin care. Founded in 1957 and headquartered in Humlebæk, Denmark, Coloplast has established a strong presence in numerous countries, serving healthcare professionals and patients around the globe. Its strategic positioning is supported by a commitment to innovation and close collaboration with healthcare professionals to ensure the efficacy and safety of its offerings. Coloplast's competitive strengths derive from its comprehensive product portfolio and strong expertise in chronic care solutions.
Ticker
€COLOB
Sector
Primary listing
XGAT
Employees
17,083
Headquarters
Humlebæk, Denmark
Website
Coloplast A/S Metrics
BasicAdvanced
€11bn
41.18
€1.25
0.50
€3.08
5.98%
Price and volume
Market cap
€11bn
Beta
0.5
52-week high
€86.25
52-week low
€50.30
Average daily volume
7.7k
Dividend rate
€3.08
Financial strength
Current ratio
1.748
Quick ratio
1.01
Long term debt to equity
171.268
Total debt to equity
188.648
Dividend payout ratio (TTM)
246.15%
Interest coverage (TTM)
11.64%
Profitability
EBITDA (TTM)
1,139.708
Gross margin (TTM)
67.46%
Net profit margin (TTM)
7.51%
Operating margin (TTM)
27.05%
Effective tax rate (TTM)
38.85%
Revenue per employee (TTM)
€219,430
Management effectiveness
Return on assets (TTM)
9.90%
Return on equity (TTM)
14.14%
Valuation
Price to earnings (TTM)
41.183
Price to revenue (TTM)
3.091
Price to book
6.6
Price to tangible book (TTM)
-5.79
Price to free cash flow (TTM)
14.635
Free cash flow yield (TTM)
6.83%
Free cash flow per share (TTM)
3.518
Dividend yield (TTM)
5.98%
Growth
Revenue change (TTM)
0.90%
Earnings per share change (TTM)
-53.68%
3-year revenue growth (CAGR)
5.22%
10-year revenue growth (CAGR)
6.88%
3-year earnings per share growth (CAGR)
-25.50%
10-year earnings per share growth (CAGR)
6.86%
3-year dividend per share growth (CAGR)
4.77%
10-year dividend per share growth (CAGR)
11.14%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs